Dentsply Sirona Stock Price, News & Analysis

DENTSPLY SIRONA Inc. (Nasdaq: XRAY) is described as the world’s largest diversified manufacturer of professional dental products and technologies. With over a century of activity in the dental industry, the company develops, manufactures, and markets a broad solutions offering that spans dental and oral health products as well as other consumable medical devices. According to its public disclosures, Dentsply Sirona focuses on providing high-quality, effective and connected solutions intended to advance patient care and support better and safer dental treatment.

The company is headquartered in Charlotte, North Carolina, and its shares are listed in the United States on Nasdaq under the symbol XRAY. It operates within the dental equipment and supplies manufacturing industry and the broader manufacturing sector. Public statements emphasize a portfolio built around professional dental products and technologies, supported by a strong set of brands used by dental professionals and patients worldwide.

Business focus and product scope

Dentsply Sirona’s business centers on professional dental products and technologies and other consumable medical devices. Company descriptions in press releases and filings consistently refer to a “comprehensive solutions offering” in dental and oral health, under a portfolio of established brands. Its products are positioned to support clinical workflows and patient care in professional settings, with an emphasis on connected solutions that link different steps of diagnosis and treatment.

In addition to dental and oral health products, the company includes other consumable medical devices in its offering. Through its Wellspect Healthcare business, which Dentsply Sirona has decided to retain as part of its portfolio, the company participates in the global continence care market. Wellspect provides bladder and bowel care products under brands such as LoFric and Navina, and has been described as a category leader in continence care with a long operating history.

Connected dentistry and technology orientation

Recent company communications highlight a focus on “connected dentistry” and connected technology solutions. Dentsply Sirona describes an ecosystem that links devices, software and services from scanning to design and manufacturing, with the goal of helping dental practices operate more efficiently and support improved patient outcomes. The firm’s Connected Technology Solutions segment is referenced in its financial reporting, reflecting the importance of digital and technology-enabled offerings within its portfolio.

The company’s public comments also reference the use of digital, AI and transformation initiatives within its organization, including a Transformation Office that encompasses AI and automation projects. These initiatives are intended to support decision-making, streamline operations and enhance analytics as part of its internal Return-to-Growth action plan.

Portfolio structure and segments

In its financial reporting, Dentsply Sirona identifies multiple segments, including Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. These segments reflect different areas of its product and solutions portfolio, ranging from technology-focused offerings to essential dental products and specialized solutions in orthodontics, implants and continence care. Segment disclosures indicate that the company evaluates performance and growth across these distinct areas.

The Wellspect Healthcare business, retained after a review of strategic alternatives, is described as a leading provider of bladder and bowel care products with a long track record and a product portfolio built around recognized brands. Company statements indicate that Wellspect has delivered organic sales growth in recent years and is viewed as an important contributor to the broader Dentsply Sirona portfolio.

Strategic priorities and Return-to-Growth plan

In connection with its third quarter 2025 results, Dentsply Sirona outlined a Return-to-Growth action plan. According to the company, this plan is designed to improve performance and position the business for sustained, profitable growth. The plan is organized around four pillars: putting customers at the center, reigniting the U.S. business, empowering people to power performance, and evolving operations to fuel innovation.

Putting customers at the center involves enhancing the customer experience by simplifying processes, empowering field and commercial teams, and strengthening global service capabilities. Reigniting the U.S. business focuses on improving commercial execution and deepening customer relationships in the United States. Empowering people to power performance includes building a high-performing culture, strengthening leadership and advancing digital, AI and transformation initiatives through a Transformation Office. Evolving operations to fuel innovation emphasizes streamlining operations, investing in research and development, and increasing training and education for clinicians.

Corporate governance and leadership developments

Dentsply Sirona’s SEC filings and press releases describe several governance and leadership actions. The company has reported leadership changes in key roles, including its chief commercial officer, finance leadership and legal leadership. It also disclosed the formation of a Growth and Value Creation Committee of the Board of Directors to oversee and support execution of the Return-to-Growth action plan.

In addition, the company has discussed retention equity incentive awards for certain executives in connection with leadership transitions, and it has reported on the conclusion of an SEC Division of Enforcement investigation related to prior financial reporting matters. The company has stated that the SEC does not intend to recommend enforcement action in connection with that investigation.

Capital allocation and shareholder returns

Dentsply Sirona has disclosed that it pays a quarterly cash dividend on its common stock. For example, the Board of Directors has announced a quarterly cash dividend and described an indicated annual rate per share. The company has also reported returning cash to stockholders through dividends over specified reporting periods, as part of its broader capital allocation approach.

In its financial communications, the company provides both GAAP and non-GAAP metrics, including adjusted gross margin, adjusted EBITDA margin and adjusted earnings per share, and explains that these measures exclude certain items. It also provides constant currency information to describe the impact of foreign exchange on reported results.

Regulatory disclosures and risk communication

Through its SEC filings, Dentsply Sirona reports material events such as leadership changes, financial results, strategic reviews and regulatory developments. The company uses Form 8-K to disclose results of operations, changes in executive officers, retention awards and other events. It also includes forward-looking statements and references to risk factors contained in its annual and quarterly reports filed with the SEC.

Company communications emphasize that forward-looking statements are subject to risks and uncertainties, and they reference risk factor sections in its Form 10-K and Form 10-Q filings. The firm notes that it does not undertake to update forward-looking statements except as required by law and that investors should consider the risks described in its SEC filings when evaluating the company.

Geographic and segment performance context

In its quarterly financial disclosures, Dentsply Sirona provides information on net sales by segment and geography. The company reports segment-level changes in net sales for Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions and Wellspect Healthcare. It also reports geographic performance for the United States, Europe and the Rest of World, including reported and constant currency changes.

These disclosures indicate that the company monitors performance across regions and product categories, and that factors such as tariffs, volumes of equipment, implants and prosthetics, and foreign currency movements can affect segment and geographic results. The company has also reported non-cash impairment charges related to goodwill and other indefinite-lived intangible assets in certain segments, citing lower-than-expected volumes and tariff impacts.

Position within the dental industry

Across multiple press releases, Dentsply Sirona describes itself as the world’s largest diversified manufacturer of professional dental products and technologies. It highlights more than a century of innovation and service to the dental industry and patients worldwide, and it emphasizes a portfolio of dental and oral health products and other consumable medical devices offered under a strong set of brands.

The company’s communications also reference its role in advancing connected dentistry, working with distribution partners to provide access to integrated ecosystems that link devices, software and services. These statements underscore its positioning as a large-scale manufacturer in the dental industry with a focus on technology, connectivity and professional products.